BLANCA PYLE: Open Payments
NPI 1952426611 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,689 in 64 payments from 23 companies in 2025. Trend: 2023 $1,013 · 2024 $1,719 · 2025 $1,689
Food & beverage: $1,689
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $379 |
| ABBVIE INC. | 11 | $221 |
| Gilead Sciences, Inc. | 3 | $182 |
| PFIZER INC. | 10 | $141 |
| Novo Nordisk Inc | 4 | $107 |
| Lilly USA, LLC | 3 | $62 |
| Amgen Inc. | 3 | $61 |
| Sumitomo Pharma America, Inc. | 3 | $57 |
| Otsuka America Pharmaceutical, Inc. | 2 | $49 |
| GlaxoSmithKline, LLC. | 3 | $49 |
Products named: NEXIUM, Biktarvy, AIRSUPRA, BREZTRI, QULIPTA, Wegovy, VRAYLAR, NURTEC ODT.
Industry payments across CO — which companies pay providers there.
